Executive Director, Global Clinical Development, Early Hematology and Cell Therapy

Bristol Myers Squibb•Madison, CA

14h•Onsite

About The Position

The Executive Director will set the clinical development strategy for assets or indications within Early Clinical Development with a focus on malignancy hematology indications. This role will directly supervise the work of multiple Clinical Trial Physicians and Clinical Scientists, providing career development opportunities for individuals across a wide variety of backgrounds and experience levels. This role will include above disease/indication strategy work focusing on malignant hematology indications including but not limited to lymphoma, multiple myeloma, acute myeloid leukemia and others. The role will be foundational in working with teams in Research and Late Clinical Development to support ID1, ID2 and ID3 transitions and achievement of Proof of Concept (PoC), providing insights into biology, translational elements as well as overall benefit risk assessments. The role will supervise the development of differentiated and strategic Clinical Development Plans (CDPs) for multiple early assets and support a broad program of work from pre-IND through to PoC. The role will support of across portfolio activities in line with Clinical Excellence, including e.g. Protocol Review Committee, extensive Business Development activities and Quality and Compliance leadership. The role will report directly to the Vice President, Early Hematology and Cell Therapy, and will deputize as required. The role will be a core member of the early clinical development leadership team.

Requirements

MD (PhD or other high level degree optional)
Greater than 10 years of extensive clinical trial, drug development, and regulatory experience, in addition to a strong scientific background.
Management experience is preferred since this individual will manage a group of professionals including MDs or PhDs or PharmDs with clinical research experience.
Understand early-stage drug development.
Extensive experience designing and conducting Phase I and II clinical trials.
Demonstrable success navigating health authority interactions.
Experience interacting with business development, particularly helping to evaluate the technical and franchise aspects for potential opportunities that shape the hematology clinical development strategy.
Proven track record in managing complex clinical programs.
Deep understanding of biology, targets and translational science.
Extensive experience of work with health authorities.
Proven differentiated ability to support and manage across the totality of the early drug development spectrum.
Ability to execute the BMS R&D People Strategy, and lead and develop a matrix team.
Highly effective leader capable of working with Commercial, Medical, and all research functions of the company from Research through Regulatory.
Comfortable with cross-functional drug and product development teams and managing in a matrix environment.
Skilled at interacting externally, and at speaking engagements.
Skilled at attracting, developing, and retaining skilled professionals.

Nice To Haves

Global experiences is a plus since this position has responsibility for strategy and clinical research in multiple geographies.

Responsibilities

Create and communicate a vision for designing, conducting and executing innovative clinical development plans.
Supervise the development, monitoring, analysis and interpretation of clinical trials.
Supervise and have accountability for the clinical components of regulatory interactions.
Help drive overall strategy for malignant hematology while ensuring a franchise overall portfolio view.
Provide strategic insights into the clinical development plans.
Lead clinical input for search and evaluation activities in business development and diligence efforts.
Chair departmental Staff Meetings, PRC and represent governance meetings on an ad hoc basis.
Build a franchise reputation that attracts innovators to bring their ideas to BMS Drug Development.
Create a Clinical Development strategy to develop programs from research into First-In-Human testing and up to the achievement of Proof of Concept.
Lead and develop a group of Clinical Development professionals whose therapeutic area focus is in a malignant hematology and will ensure scientific and technical excellence of clinical development programs and deliverables.
Recruit, develop and retain strong talent.
Mentor talent/staff.
Establish an effective and ethical culture that encourages teamwork, peer review, promotes cooperation and provides a supportive culture.
Develop a culture that values diversity of thought, supports coaching, fosters accountability and integrity, and supports process excellence and continuous improvement.
Oversee select team budget and headcount.
Work closely with colleagues in BMS Research, Development, Regulatory, Medical, Commercial and other key functional areas on a global basis.
Build relationships with thought leaders, physicians, and patient advocacy groups outside of BMS.
Be recognized internally and externally as an expert in the field.
Partner and interact with colleagues from Research and Late Development and will assure a seamless transition into late stage development (Phase II-III trials.).
Governance participation ad hoc as designated.
PRC Chair ad hoc as needed.
Signature Authority for: CSRs, Health Authority Interactions, DMC Charters, And other clinical accountable documents delegated as needed.

Benefits

Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume